Article
Teen vaping in the time of COVID-19
occurred...
News
Switch to integrase inhibitor regimen safe and effective
Forty-eight weeks after the switch, virologic suppression was maintained among 94.3% of those on an integrase inhibitor–based regimen.
News
TKI choice key for fit/unfit patients with Ph+ALL
Ponatinib (Iclusig) is associated with high response rates in combination therapy, but toxicities may be too great for less fit patients.
News
Fatal pediatric melanomas diverse in presentation
One-fourth of fatal pediatric melanomas arose in association with congenital melanocytic nevi.
News
Coronavirus-associated aspergillosis increased 30-day mortality risk
Nearly one-third of patients on mechanical ventilation for COVID-19 had probable coronavirus-associated pulmonary aspergillosis.
News
Ultrasound, cardiac CT valuable in COVID-19 assessment
An expert panel of the American College of Cardiology offers evidence-based guidance for evaluating cardiac complications of COVID-19 infections...